Mechanized Lp(a) method as marker for coronary artery disease (CAD) illustrates the importance of very high Lp(a) levels.

被引：0
|
作者：
Levinson, SS [1 ]
Kaplan, IV [1 ]
Hobbs, GA [1 ]
机构：
[1] Univ Louisville, Dept Pathol, VAMC, Lab Serv, Louisville, KY 40292 USA
来源：
CLINICAL CHEMISTRY | 1998年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
315
引用
收藏
页码：A73 / A73
页数：1
相关论文
共 47 条
  • [31] LIPIDS AND LP(A) LIPOPROTEIN LEVELS AND CORONARY-ARTERY DISEASE IN SUBJECTS WITH NON-INSULIN-DEPENDENT DIABETES-MELLITUS
    OBRIEN, T
    NGUYEN, TT
    HARRISON, JM
    BAILEY, KR
    DYCK, PJ
    KOTTKE, BA
    MAYO CLINIC PROCEEDINGS, 1994, 69 (05) : 430 - 435
  • [32] The relationship of Lp(a) levels with coronary artery disease is genotype dependent for three apo(a) gene polymorphisms in Asian Indians in Singapore.
    Heng, CK
    Ho, WFK
    Saha, N
    Tong, MC
    Tan, YS
    Kamboh, MI
    AMERICAN JOURNAL OF HUMAN GENETICS, 1999, 65 (04) : A205 - A205
  • [33] Involvement of polymorphisms in the chemokine system in the susceptibility for coronary artery disease (CAD).: Coincidence of elevated Lp(a) and MCP-1-2518 G/G genotype in CAD patients
    Szalai, C
    Duba, J
    Prohászka, Z
    Kalina, A
    Szabó, T
    Nagy, B
    Horváth, L
    Császár, A
    ATHEROSCLEROSIS, 2001, 158 (01) : 233 - 239
  • [34] QUANTITATIVE-ANALYSIS OF THE EFFECT OF APO(A) AND THE LDL RECEPTOR LOCI ON LP(A) SERUM LEVELS IN 24 CORONARY-ARTERY DISEASE FAMILIES
    DEMEESTER, C
    BU, X
    PUPPIONE, D
    LUSIS, AJ
    ROTTER, JI
    CLINICAL RESEARCH, 1992, 40 (01): : A102 - A102
  • [35] HIGH SERUM ENDOCAN IS A MARKER OF ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND CORONARY ARTERY DISEASE (CAD)
    Elsheikh, E.
    Younoszai, Z.
    Otgonsuren, M.
    Hunt, S.
    Raybuck, B.
    Younossi, Z. M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S529 - S530
  • [36] SERUM LP(A) LIPOPROTEIN LEVELS IN PATIENTS WITH CORONARY-ARTERY DISEASE AND THE INFLUENCE OF LONG-TERM N-3 FATTY-ACID SUPPLEMENTATION
    ERITSLAND, J
    ARNESEN, H
    BERG, K
    SELJEFLOT, I
    ABDELNOOR, M
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 1995, 55 (04): : 295 - 300
  • [37] Lipoprotein-associated phospholipase (Lp-PLA2), C-reactive protein (CRP) and coronary artery disease (CAD) among persons with type I diabetes
    Orchard, T. J.
    Miller, R. G.
    Costacou, T.
    Evans, R. W.
    DIABETOLOGIA, 2007, 50 : S508 - S508
  • [38] High Serum Lp(a) Levels Are Associated With Subclinical 3-Vessel and Left Main Coronary Disease, Severe Stenoses and Plaque Volume in Apparently Healthy African Americans
    Kral, Brian G.
    Becker, Lewis C.
    Qayyum, Rehan
    Vaidya, Dhananjay
    Yanek, Lisa R.
    Fishman, Elliot K.
    Becker, Diane M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2014, 34
  • [39] Increased plasma lipoprotein-associated phospholipase A2 (Lp-PLA2) levels are related to good collateral development in patients with isolated left coronary artery disease
    Orem, Cihan
    Kahraman, Nuray
    Orem, Asim
    Ucar, Utku
    Yucesan, Fulya Balaban
    Mentese, Ahmet
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2011, 148 (01) : 117 - 119
  • [40] Hyperlipoproteinemia(a) in coronary artery disease patients: who are patients with very high levels and how do they respond to the PCSK9 antibody therapy?
    Novakovic, M.
    Trsan, J.
    Krevel, B.
    Cevc, M.
    Fras, Z.
    Jug, B.
    EUROPEAN HEART JOURNAL, 2023, 44
12345